The Board of Directors and major shareholders of Sanitas AB (the „Company“) have initiated a review of the Company's strategic options to explore ways to enhance shareholder value. The review of strategic options may, or may not, lead to any proposal being made to shareholders and the Company continues to remain focused on the execution of its operating plan. Merrill Lynch International has been appointed as a financial advisor in connection with the review. Further announcements will be made as appropriate. Alina Nausedaite Jurist Tel. +370 37 20 06 62